U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240662) titled 'Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma' on Sept. 29. Brief Summary: The ... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243301) titled 'Thread Implantation Acupuncture vs Sham on Acute Pain and Quality of Life After Laparoscopi... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07243431) titled 'Knowledge About the Administration and Regulation of High Alert Medications Among Nurses in... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240792) titled 'Development of a College Student-Delivered Cognitive-Behavioral Therapy (CBT) Intervention ... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241754) titled 'Predictors of Anti-seizure Medication Resistance in Pediatric Epilepsy' on Nov. 17. Brief ... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241390) titled 'A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerot... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240974) titled 'Safety and Efficacy of ZZSW-01 in Relapsed/Refractory B-cell Malignancies' on Sept. 03. Br... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240480) titled 'Assessing the Turkish DDIVAT for Visual Acuity Measurement' on Nov. 16. Brief Summary: The... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241260) titled 'Hydrate Heroes for Improving Brain Function & Mood' on July 17. Brief Summary: The primary... Read More
U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240649) titled 'Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications' on Oct. 26. Bri... Read More